SCHEMBL1785141

SCHEMBL1785141

COC(=O)c1cc(NN)c(C)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
ABL1 P00519 1/20 0.42
KDM4E B2RXH2 2/20 0.41
PTGS2 P35354 1/20 0.40
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 2/20 0.38
MAPT P10636 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
NQO2 P16083 4/20 0.38
ALDH1A1 P00352 4/20 0.38
TSHR P16473 1/20 0.38
CISD2 Q8N5K1 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1784371 0.86 GAA (0.50) GAAABL1KDM4EMEN1LMNA
SCHEMBL15048881 0.83 MAPT (0.50) KDM4EPTGS2MEN1LMNAKMT2A
SCHEMBL14590043 0.82 GAA (0.47) GAAABL1KDM4EPTGS2MEN1
SCHEMBL1785519 0.82 GAA (0.58) GAAABL1KDM4EMEN1LMNA
Hydrochloric Acid SCHEMBL1786171 0.81 GAA (0.56) GAAABL1KDM4EMEN1LMNA
Hydrochloric Acid SCHEMBL1787107 0.81 GAA (0.46) GAAABL1KDM4EMEN1LMNA
SCHEMBL7863946 0.80 GAA (0.50) GAAABL1KDM4EPTGS2MEN1
SCHEMBL31508216 0.79 GAA (0.54) GAAABL1KDM4EMEN1LMNA
SCHEMBL1786192 0.79 GAA (0.54) GAAABL1KDM4EMEN1LMNA
Hydrochloric Acid SCHEMBL9623221 0.79 GAA (0.54) GAAABL1KDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2013-08-08 US disclosed
EP-2607357-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS Astrazeneca AB (SE) 2013-06-26 EP disclosed
US-20120115845-A1 THERAPEUTIC AGENTS ALLEN JACK MCQUEEN (GB) 2012-05-10 US disclosed
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2011-05-26 US disclosed
EP-2205576-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS AstraZeneca AB (SE) 2010-07-14 EP disclosed
US-20090186870-A1 Therapeutic Agents - 802 ASTRAZENECA AB (SE) 2009-07-23 US disclosed
WO-2009047558-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R GAA 1879/4885ABL1 1364/4885KDM4E 1188/4885
US-20120115845-A1 THERAPEUTIC AGENTS GPR119, MC2R, MC4R GAA 402/4885ABL1 898/4885KDM4E 3215/4885
US-20090186870-A1 Therapeutic Agents - 802 GPR119, SLC5A2, MC2R GAA 549/4885ABL1 983/4885KDM4E 3524/4885
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R GAA 1879/4885ABL1 1364/4885KDM4E 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.